Follow the 바이오플러스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오플러스 has logged 58 insider filings. Market capitalisation: €211.7bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 정현규. All data is accessible without an account.
58
Insider Decl.
n/a
Thresholds
n/a
12 ops.
Buy Volume
n/a
19 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,706 of 28,065 companies
56.2
score / 100
Value
45
Quality
67
FCF yld-16%
Earn yld7.1%
EV/EBITDA12.4x
ROE11%
Gross mgn67%
Net mgn17%
Debt/EBITDA2.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.